Literature DB >> 33883752

Deep brain stimulation electrode position impact on parkinsonian non-motor symptoms.

Jan Bardon1, Sandra Kurcova1, Monika Chudackova1, Pavel Otruba1, David Krahulik2, Martin Nevrly1, Petr Kanovsky1, Jana Zapletalova3, Jan Valosek1,4, Petr Hlustik1, Miroslav Vastik1, Marketa Vecerkova1, Lenka Hvizdosova1, Katerina Mensikova1, Egon Kurca5, Stefan Sivak5.   

Abstract

BACKGROUND: In this study we evaluated the impact of location of deep brain stimulation electrode active contact in different parts of the subthalamic nucleus on improvement of non-motor symptoms in patients with Parkinson's disease.
METHODS: The subthalamic nucleus was divided into two (dorsolateral/ventromedial) and three (dorsolateral, medial, ventromedial) parts. 37 deep brain stimulation electrodes were divided according to their active contact location. Correlation between change in non-motor symptoms before and one and four months after deep brain stimulation electrode implantation and the location of active contact was made.
RESULTS: In dividing the subthalamic nucleus into three parts, no electrode active contact was placed ventromedially, 28 active contacts were located in the medial part and 9 contacts were placed dorsolaterally. After one and four months, no significant difference was found between medial and dorsolateral positions. In the division of the subthalamic nucleus into two parts, 13 contacts were located in the ventromedial part and 24 contacts were placed in the dorsolateral part. After one month, significantly greater improvement in the Non-motor Symptoms Scale for Parkinson's disease (P=0.045) was found on dorsolateral left-sided stimulation, but no significant differences between the ventromedial and dorsolateral positions were found on the right side.
CONCLUSION: This study demonstrated the relationship between improvement of non-motor symptoms and the side (hemisphere, left/right) of the deep brain stimulation electrode active contact, rather than its precise location within specific parts of the subthalamic nucleus in patients treated for advanced Parkinson's disease.

Entities:  

Keywords:  Parkinson's disease; deep brain stimulation; non-motor symptoms

Mesh:

Year:  2020        PMID: 33883752     DOI: 10.5507/bp.2020.034

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  23 in total

1.  Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.

Authors:  Haidar Salimi Dafsari; Jan Niklas Petry-Schmelzer; K Ray-Chaudhuri; Keyoumars Ashkan; Luca Weis; Till A Dembek; Michael Samuel; Alexandra Rizos; Monty Silverdale; Michael T Barbe; Gereon R Fink; Julian Evans; Pablo Martinez-Martin; Angelo Antonini; Veerle Visser-Vandewalle; Lars Timmermann
Journal:  Brain Stimul       Date:  2018-03-16       Impact factor: 8.955

2.  Non-motor outcomes depend on location of neurostimulation in Parkinson's disease.

Authors:  Jan Niklas Petry-Schmelzer; Max Krause; Till A Dembek; Andreas Horn; Julian Evans; Keyoumars Ashkan; Alexandra Rizos; Monty Silverdale; Wibke Schumacher; Carolin Sack; Philipp A Loehrer; Gereon R Fink; Erich T Fonoff; Pablo Martinez-Martin; Angelo Antonini; Michael T Barbe; Veerle Visser-Vandewalle; K Ray-Chaudhuri; Lars Timmermann; Haidar S Dafsari
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

Review 3.  The latest evidence on target selection in deep brain stimulation for Parkinson's disease.

Authors:  Timothy Ross Lukins; Stephen Tisch; Benjamin Jonker
Journal:  J Clin Neurosci       Date:  2013-11-05       Impact factor: 1.961

Review 4.  Deep Brain Stimulation Target Selection for Parkinson's Disease.

Authors:  Christopher R Honey; Clement Hamani; Suneil K Kalia; Tejas Sankar; Marina Picillo; Renato P Munhoz; Alfonso Fasano; Michel Panisset
Journal:  Can J Neurol Sci       Date:  2016-03-15       Impact factor: 2.104

5.  Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior.

Authors:  Luc Mallet; Michael Schüpbach; Karim N'Diaye; Philippe Remy; Eric Bardinet; Virginie Czernecki; Marie-Laure Welter; Antoine Pelissolo; Merle Ruberg; Yves Agid; Jérôme Yelnik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-07       Impact factor: 11.205

6.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

7.  Somatotopic organization of the primate Basal Ganglia.

Authors:  Atsushi Nambu
Journal:  Front Neuroanat       Date:  2011-04-20       Impact factor: 3.856

8.  Optimal deep brain stimulation site and target connectivity for chronic cluster headache.

Authors:  Harith Akram; Sarah Miller; Susie Lagrata; Marwan Hariz; John Ashburner; Tim Behrens; Manjit Matharu; Ludvic Zrinzo
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

9.  Comparison of Efficacy of Deep Brain Stimulation of Different Targets in Parkinson's Disease: A Network Meta-Analysis.

Authors:  Zhiqi Mao; Zhipei Ling; Longsheng Pan; Xin Xu; Zhiqiang Cui; Shuli Liang; Xinguang Yu
Journal:  Front Aging Neurosci       Date:  2019-02-22       Impact factor: 5.750

10.  Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study.

Authors:  Sandra Kurcova; Jan Bardon; Miroslav Vastik; Marketa Vecerkova; Monika Frolova; Lenka Hvizdosova; Martin Nevrly; Katerina Mensikova; Pavel Otruba; David Krahulik; Egon Kurca; Stefan Sivak; Jana Zapletalova; Petr Kanovsky
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.